2010•Zhongguo linchuang yaolixue yu zhiliaoxueRequires access

Pharmacokinetic reseach of anti-cancer drug-Gemcitabine in vivo model by microdialysis technique

Huang Xueqin

Open publisher page 0 citations

Abstract

AIM:To estabalish the methodology of microdialysis technique in pharmacokinetic(PK) reseach of anticancer drugs in vivo. METHODS:Gemcitabine(GEM) was injected into mice's tail vein.The microdialysate samples from blood were collected after dosing in gemcitabine-treated mices.The concentration of GEM was detected real-time continuously and pharmacokinetic parameters were evaluated.RESULTS:The recovery rate of GEM in vivo was(11.9±2.0)%.It showed that the pharmacokinetics of gemcitabine was two-compartment model in vivo and the elimination and distribution of GEM meets the first kinetics.There were no serious side effects in model mice.CONCLUSION:Microdialysis can be successfully employed in living body to detect the concentration of GEM continuously,which prompts it is possible to study the PK of anticancer drugs in malignant tissues in vivo.

About this research paper

What this paper is about

AIM:To estabalish the methodology of microdialysis technique in pharmacokinetic(PK) reseach of anticancer drugs in vivo. METHODS:Gemcitabine(GEM) was injected into mice's tail vein.The microdialysate samples from blood were collected after dosing in gemcitabine-treated mices.The concentration of GEM was detected real-time continuously and pharmacokinetic parameters were evaluated.RESULTS:The recovery rate of GEM in vivo was(11.9±2.0)%.It showed that the pharmacokinetics of gemcitabine was two-compartment model in vivo and the elimination and distribution of GEM meets the first kinetics.There were no serious side effects in model mice.CONCLUSION:Microdialysis can be successfully employed in living body to detect the concentration of GEM continuously,which prompts it is possible to study the PK of anticancer drugs in malignant tissues in vivo.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To estabalish the methodology of microdialysis technique in pharmacokinetic(PK) reseach of anticancer drugs in vivo. METHODS:Gemcitabine(GEM) was injected into mice's tail vein.The microdialysate samples from blood were collected after dosing in gemcitabine-treated mices.The concentration of GEM was detected real-time continuously and pharmacokinetic parameters were evaluated.RESULTS:The recovery rate of GEM in vivo was(11.9±2.0)%.It showed that the pharmacokinetics of gemcitabine was two-compartment model in vivo and the elimination and distribution of GEM meets the first kinetics.There were no serious side effects in model mice.CONCLUSION:Microdialysis can be successfully employed in living body to detect the concentration of GEM continuously,which prompts it is possible to study the PK of anticancer drugs in malignant tissues in vivo.

Key concepts: Microdialysis, Pharmacokinetics, Gemcitabine, In vivo, Pharmacology, Chemistry, Drug, Distribution (mathematics)

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetic reseach of anti-cancer drug-Gemcitabine in vivo model by microdialysis technique — Research Paper | ScholarLens